Findings of the International Nosocomial Infection Control Consortium (INICC), Part III: Effectiveness of a multidimensional infection control approach to reduce central line-associated bloodstream infections in the neonatal intensive care units of 4 developing countries

Infection Control and Hospital Epidemiology

Volumn 34, Issue 3, 2013, Pages 229-237

  Rosenthal, Victor Daniel ^a   Dueñas, Lourdes ^b   Sobreyra Oropeza, Martha ^c   Ammar, Khaldi ^d   Navoa Ng, Josephine Anne ^e   Casares, Ana Concepción Bran de ^b   Machuca, Lilian de Jesús ^b   Ben Jaballah, Nejla ^d   Hamdi, Asma ^d   Villanueva, Victoria D ^e   Tolentino, María Corazon V ^e  

^a International Nosocomial Infection Control Consortium   (Argentina)

^b Hospital Nacional de Ninos Benjamin Bloom   (El Salvador)

^c Hospital de la Mujer   (Mexico)

^d CHILDREN S HOSPITAL   (Tunisia)

^e ST LUKE S MEDICAL CENTER   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOODSTREAM INFECTION; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HAND WASHING; HEALTH CARE PERSONNEL; HOSPITAL BED; HOSPITAL INFECTION; HOSPITALIZED INFANT; HUMAN; INCIDENCE; INFECTION CONTROL; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL SCALING; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PATIENT EDUCATION;

EID: 84873645944     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/669511     Document Type: Article

References (56)

1. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S22-S30.
2. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725-2732.
3. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160(3):976-981.
4. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med 2006;34(8):2084-2089.
5. Powers RJ, Wirtschafter DW. Decreasing central line associated bloodstream infection in neonatal intensive care. Clin Perinatol 2010;37(1):247-272.
6. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011; 14(2):381-386.
7. Higuera F, Rangel-Frausto MS, Rosenthal VD, et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007;28(1):31-35.
8. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control 2003;31(8):475-480.
9. Rosenthal VD, Guzman S, Migone O, Safdar N. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control 2005;33(3): 157-161.
10. Rosenthal VD, Udwadia FE, Muñoz HJ, et al. Time-dependent analysis of extra length of stay and mortality due to ventilatorassociated pneumonia in intensive-care units of ten limitedresources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Epidemiol Infect 2011; 139(11):1757-1763.
11. Rosenthal VD, Dwivedy A, Calderon ME, et al. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J Infect 2011;62(2):136-141.
12. Barnett AG, Graves N, Rosenthal VD, Salomao R, Rangel-Frausto MS. Excess length of stay due to central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico. Infect Control Hosp Epidemiol 2010;31(11): 1106-1114.
13. Ramirez Barba EJ, Rosenthal VD, Higuera F, et al. Deviceassociated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control 2006;34(4): 244-247.
14. Rosenthal VD. Device-associated nosocomial infections in limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control 2008;36(10):S171. e7-S171. e12.
15. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003;31(5): 291-295.
16. Tarricone R, Torbica A, Franzetti F, Rosenthal VD. Hospital costs of central line-associated bloodstream infections and costeffectiveness of closed vs. open infusion containers: the case of intensive care units in Italy. Cost Eff Resour Alloc 2010;8:8.
17. Moreno CA, Rosenthal VD, Olarte N, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol 2006; 27(4):349-356.
18. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 2004;25(3):251-255.
19. Rosenthal VD, Lynch P, Jarvis WR, et al. Socioeconomic impact on device-associated infections in limited-resource neonatal intensive care units: findings of the INICC. Infection 2011;39(5): 439-450.
20. Townsend TR, Wenzel RP. Nosocomial bloodstream infections in a newborn intensive care unit: a case-matched control study of morbidity, mortality and risk. Am J Epidemiol 1981;114(1): 73-80.
21. Pessoa-Silva CL, Miyasaki CH, de Almeida MF, Kopelman BI, Raggio RL, Wey SB. Neonatal late-onset bloodstream infection: attributable mortality, excess of length of stay and risk factors. Eur J Epidemiol 2001;17(8):715-720.
22. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 pt 1):285-291.
23. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA 2004;292(19): 2357-2365.
24. Shah DK, Doyle LW, Anderson PJ, et al. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008;153(2):170-175, 175. e1.
25. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009;123(5):1314-1319.
26. Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 2007;44(4):459-463.
27. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355(9218):1864-1868.
28. Apisarnthanarak A, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ. Effectiveness of a catheter-associated bloodstream infection bundle in a Thai tertiary care center: a 3-year study. Am J Infect Control 2010;38(6):449-455.
29. Rosenthal VD, Ramachandran B, Dueñas L. Findings of the International Nosocomial Infection Control Consortium (INICC), part I: effectiveness of a multidimensional infection control approach on catheter-associated urinary tract infection rates in pediatric intensive care units of 6 developing countries. Infect Control Hosp Epidemiol 2012;33(7):696-703.
30. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36(5):309-332.
31. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005; 33(7):392-397.
32. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32(10):2014-2020.
33. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15(4 pt 1):231-238.
34. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52(9):e162-e193.
35. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: national evidencebased guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007;65(suppl 1): S1-S64.
36. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect 2003;54(4):288-293.
37. Luebke MA, Arduino MJ, Duda DL, et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control 1998;26(4):437-441.
38. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use: internal medicine house staff participate in a successful quality improvement project. Arch Intern Med 1994;154(16):1829-1832.
39. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med 1992;116(9):737-738.
40. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39(4 suppl 1):S1-S34.
41. Royer T. Implementing a better bundle to achieve and sustain a zero central line-associated bloodstream infection rate. J Infus Nurs 2010;33(6):398-406.
42. Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control 2008;36(9):e1-e12.
43. Sax H, Allegranzi B, Chraiti MN, Boyce J, Larson E, Pittet D. The World Health Organization hand hygiene observation method. Am J Infect Control 2009;37(10):827-834.
44. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977;296(23):1305-1309.
45. Emori TG, Culver DH, Horan TC, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19(1):19-35.
46. World Bank classification of economies. World Bank website. http://web.worldbank.org/WBSITE/EXTERNAL/DATA STATISTICS/0, contentMDK:20421402-pagePK:64133150-piPK:64133175-theSitePK:239419,00.html. Published 2007. Accessed October 5, 2008.
47. Tseng YC, Chiu YC, Wang JH, Lin HC, Su BH, Chiu HH. Nosocomial bloodstream infection in a neonatal intensive care unit of a medical center: a three-year review. J Microbiol Immunol Infect 2002;35(3):168-172.
48. Landre-Peigne C, Ka AS, Peigne V, Bougere J, Seye MN, Imbert P. Efficacy of an infection control programme in reducing nosocomial bloodstream infections in a Senegalese neonatal unit. J Hosp Infect 2011;79(2):161-165.
49. Mahieu LM, De Dooy JJ, Lenaerts AE, Ieven MM, De Muynck AO. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. J Hosp Infect 2001;48(1):20-26.
50. Pronovost PJ, Marsteller JA, Goeschel CA. Preventing bloodstream infections: a measurable national success story in quality improvement. Health Aff (Millwood) 2011;30(4):628-634.
51. Schulman J, Stricof R, Stevens TP, et al. Statewide NICU centralline-associated bloodstream infection rates decline after bundles and checklists. Pediatrics 2011;127(3):436-444.
52. Haley RW, Quade D, Freeman HE, Bennett JV. The SENIC Project: study on the efficacy of nosocomial infection control (SENIC Project): summary of study design. Am J Epidemiol 1980;111(5):472-485.
53. Hughes JM. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy 1988;34(6):553-561.
54. Rosenthal VD, Maki DG, Rodrigues C, et al. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries. Infect Control Hosp Epidemiol 2010;31(12):1264-1272.
55. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37(10): 783-805.
56. Rosenthal VD, Jarvis WR, Jamulitrat S, et al. Socioeconomic impact on device-associated infections in pediatric intensive care units of 16 limited-resource countries: International Nosocomial Infection Control Consortium findings. Pediatr Crit Care Med 2012;13(4):399-406.